Learn how Prognos Health and Datavant are transforming & improving the way life sciences can access an extensive network of integrated real world data sources to define an ideal patient cohort as well as key demographic, therapeutic & customer insights. Understand how an enhanced ability to identify & select patient-level data speeds time to value over the traditional method of linking, purchasing & mining data from multiple sources over many months of time. Join Theresa Greco, Chief Commercial Officer, Prognos Health, & Su Huang, Head of Data Strategy, Datavant, & see it’s now possible to access and design a HIPAA-compliant, multi-source patient cohort that is application-ready in a matter of minutes. The benefits of purchasing fit-for-purpose data from the Prognos Marketplace include:
- Unprecedented flexibility in selecting cohort criteria
- Expansive ecosystem linkable via Datavant tokenization engine
- One patient-centric Marketplace to acquire all relevant and complementary records
- One vendor and contract for acquisition of multi-source data
- Delivery within hours of contract signature
- Flexible BYOD options including secure private cloud